Sanofi (SNY) Equity Average (2016 - 2025)
Sanofi (SNY) has disclosed Equity Average for 9 consecutive years, with $83.0 billion as the latest value for Q4 2025.
- Quarterly Equity Average rose 2.11% to $83.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $83.0 billion through Dec 2025, up 2.11% year-over-year, with the annual reading at $82.3 billion for FY2025, 0.34% changed from the prior year.
- Equity Average hit $83.0 billion in Q4 2025 for Sanofi, up from $81.2 billion in the prior quarter.
- In the past five years, Equity Average ranged from a high of $83.0 billion in Q4 2025 to a low of $76.9 billion in Q4 2021.
- Historically, Equity Average has averaged $79.3 billion across 5 years, with a median of $78.0 billion in 2023.
- Biggest five-year swings in Equity Average: increased 9.39% in 2021 and later increased 0.69% in 2022.
- Year by year, Equity Average stood at $76.9 billion in 2021, then increased by 0.69% to $77.4 billion in 2022, then increased by 0.71% to $78.0 billion in 2023, then grew by 4.18% to $81.2 billion in 2024, then increased by 2.11% to $83.0 billion in 2025.
- Business Quant data shows Equity Average for SNY at $83.0 billion in Q4 2025, $81.2 billion in Q4 2024, and $78.0 billion in Q4 2023.